174 related articles for article (PubMed ID: 23332440)
1. Sociodemographic and substance use characteristics of γ hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity.
Brunt TM; Koeter MW; Hertoghs N; van Noorden MS; van den Brink W
Drug Alcohol Depend; 2013 Aug; 131(3):316-9. PubMed ID: 23332440
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of γ-hydroxybutyrate overdosing.
Korf DJ; Nabben T; Benschop A; Ribbink K; van Amsterdam JG
Eur Addict Res; 2014; 20(2):66-74. PubMed ID: 24080792
[TBL] [Abstract][Full Text] [Related]
3. Gamma-hydroxybutyrate detoxification by titration and tapering.
de Jong CA; Kamal R; Dijkstra BA; de Haan HA
Eur Addict Res; 2012; 18(1):40-5. PubMed ID: 22142784
[TBL] [Abstract][Full Text] [Related]
4. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups.
Brennan R; Van Hout MC
J Psychoactive Drugs; 2014; 46(3):243-51. PubMed ID: 25052883
[TBL] [Abstract][Full Text] [Related]
5. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.
Galloway GP; Frederick SL; Staggers FE; Gonzales M; Stalcup SA; Smith DE
Addiction; 1997 Jan; 92(1):89-96. PubMed ID: 9060200
[TBL] [Abstract][Full Text] [Related]
6. Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.
Miró Ò; Galicia M; Dargan P; Dines AM; Giraudon I; Heyerdahl F; Hovda KE; Yates C; Wood DM; Liakoni E; Liechti M; Jürgens G; Pedersen CB; O'Connor N; Markey G; Moughty A; Lee C; O'Donohoe P; Sein Anand J; Puiguriguer J; Homar C; Eyer F; Vallersnes OM; Persett PS; Chevillard L; Mégarbane B; Paasma R; Waring WS; Põld K; Rabe C; Kabata PM
Toxicol Lett; 2017 Aug; 277():84-91. PubMed ID: 28579487
[TBL] [Abstract][Full Text] [Related]
7. γ-Hydroxybutyrate: experience of 9 years of γ-hydroxybutyrate (GHB)-related incidents during rave parties in The Netherlands.
Krul J; Girbes AR
Clin Toxicol (Phila); 2011 Apr; 49(4):311-5. PubMed ID: 21563907
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
McDonough M; Kennedy N; Glasper A; Bearn J
Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
[TBL] [Abstract][Full Text] [Related]
9. Decision rules for GHB (γ-hydroxybutyric acid) detoxification: a vignette study.
Kamal RM; van Iwaarden S; Dijkstra BA; de Jong CA
Drug Alcohol Depend; 2014 Feb; 135():146-51. PubMed ID: 24380737
[TBL] [Abstract][Full Text] [Related]
10. Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project.
Dijkstra BA; Kamal R; van Noorden MS; de Haan H; Loonen AJ; De Jong CA
Drug Alcohol Depend; 2017 Jan; 170():164-173. PubMed ID: 27923198
[TBL] [Abstract][Full Text] [Related]
11. Gamma-hydroxybutyrate (GHB): a newer drug of abuse.
O'Connell T; Kaye L; Plosay JJ
Am Fam Physician; 2000 Dec; 62(11):2478-83. PubMed ID: 11130233
[TBL] [Abstract][Full Text] [Related]
12. Treatment consumption and treatment re-enrollment in GHB-dependent patients in The Netherlands.
van Noorden MS; Mol T; Wisselink J; Kuijpers W; Dijkstra BAG
Drug Alcohol Depend; 2017 Jul; 176():96-101. PubMed ID: 28531770
[TBL] [Abstract][Full Text] [Related]
13. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
[TBL] [Abstract][Full Text] [Related]
14. Gamma-hydroxybutyrate--a drug of abuse.
Drasbek KR; Christensen J; Jensen K
Acta Neurol Scand; 2006 Sep; 114(3):145-56. PubMed ID: 16911342
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of GHB and ketamine use in an Australian household survey.
Degenhardt L; Dunn M
Int J Drug Policy; 2008 Aug; 19(4):311-6. PubMed ID: 17920826
[TBL] [Abstract][Full Text] [Related]
16. Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands.
van Amsterdam JG; van Laar M; Brunt TM; van den Brink W
Regul Toxicol Pharmacol; 2012 Jun; 63(1):55-63. PubMed ID: 22440552
[TBL] [Abstract][Full Text] [Related]
17. Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma.
Zvosec DL; Smith SW; Porrata T; Strobl AQ; Dyer JE
Am J Emerg Med; 2011 Mar; 29(3):319-32. PubMed ID: 20825811
[TBL] [Abstract][Full Text] [Related]
18. Profiles of club drug users in treatment.
Maxwell JC; Spence RT
Subst Use Misuse; 2005; 40(9-10):1409-26. PubMed ID: 16048825
[TBL] [Abstract][Full Text] [Related]
19. [Detoxification of patients with GHB dependence].
de Weert-van Oene GH; Schellekens AF; Dijkstra BA; Kamal R; de Jong CA
Tijdschr Psychiatr; 2013; 55(11):885-90. PubMed ID: 24242149
[TBL] [Abstract][Full Text] [Related]
20. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
